IMDM-20 enhances neutrophilic features during 1.3 % DMSO-mediated differentiation of HL-60 cells
The promyelocytic HL-60 cell line can be differentiated toward neutrophil-like cells and has been historically used as a surrogate to study human neutrophil biology <i>in vitro</i>. Multiple differentiation protocols have been reported to generate neutrophil-like HL-60 cells, with limited consideration of how methodological variations might influence cell identity and functions. Here, we conducted a systematic search of the PubMed database, to investigate the current heterogeneity in published protocols used to differentiate HL-60 towards neutrophil-like cells. Research articles published in English between January 9th<sup>,</sup> 2020, and January 9th<sup>,</sup> 2025, were identified using the key words "neutrophil-like cell" and "HL-60". Metadata of included research papers were charted and analyzed to evaluate the most reported HL-60 cells culture protocols. A total of 71 studies published in 5 years employed 41 distinct protocols. The 3 most prevalent conditions to maintain HL-60 cells were IMDM with 20 % FBS (IMDM-20), DMEM with 10 % FBS (DMEM-10), and RPMI-1640 with 10 % FBS (RPMI-10). Over 90 % of protocols applied 1-1.57 % DMSO as differentiating agent to produce neutrophil-like cells. In the laboratory, we compared the 3 most common culture media applied during neutrophil-like cell differentiation with 1.3 % DMSO over 5 and 7 days. Using IMDM-20 led to the highest proliferation rate and cell yield during differentiation. Neutrophil-like cells produced in IMDM-20 and RPMI-10 exhibited significantly higher proportions of CD15<sup>+</sup>CD11b<sup>+</sup> cells, and significantly higher bacterial clearance compared to DMEM-10. Culture media did not affect phagocytosis, but using RPMI-10 over 5 days led to significantly higher ability to produce ROS. IMDM-20 produced significantly more IL-6 and IL-1β in culture supernatant following stimulation with opsonized <i>E. coli</i>. Overall, the results support the use of IMDM-20 with 1.3 % DMSO to differentiate HL-60 to study neutrophil biology <i>in vitro</i>.
Authors
- José Antonio Cruz-Cárdenas
- Marion E. G. Brunck (ORCID: https://orcid.org/0000-0001-8994-8276)
- Alejandra López-Arredondo (ORCID: https://orcid.org/0000-0003-3557-5122)
- Jorge Andrés Cázares-Preciado (ORCID: https://orcid.org/0000-0003-2661-584X)
- Marco V Gallardo‐Camarena (ORCID: https://orcid.org/0000-0001-7810-9637)
Institutions
- Universidad Autónoma de la Ciudad de México (MX)
- Universidad Nacional Autónoma de México (MX)
- Tecnológico de Monterrey (MX)
Publication Details
- Journal
- Biochemistry and Biophysics Reports
- Published
- 2025-08-25
- DOI
- https://doi.org/10.1016/j.bbrep.2025.102215
- Citations
- 1
- Primary Topic
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.80